
Mitotax 100mg Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Paclitaxel (100mg)
Overview Mitotax 100mg Injection
Oncaspar (100mg injectable solution) is a chemotherapy agent indicated for breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, dosage and frequency are determined individually by your physician based on your specific condition and may vary. Strict adherence to your doctor's prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinuation is only permissible upon your doctor's instruction. Common side effects include nausea, vomiting, and fatigue. Serious side effects, such as edema (hands, face), alopecia, and weight increase, are also possible. Concomitant medications may be prescribed to mitigate these effects. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests are mandatory to monitor blood cell levels and liver function. Prior to treatment, disclose any heart, liver, or kidney conditions, or use of antimicrobial drugs. Potential drug interactions exist; inform your physician of all current medications. Use during pregnancy or breastfeeding is contraindicated. Effective contraception for both partners is essential throughout treatment to prevent conception.
Uses of Mitotax 100mg Injection
Cancers of the breast, lung (non-small cell), and pancreas
Major Benefits of Mitotax 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mitotax 100mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Mitotax 100mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Mitotax 100mg Injection works:
Mitotax 100mg Injection is a chemotherapeutic agent targeting cancer cells. Its mechanism involves disrupting microtubule networks, essential for cancer cell division and proliferation. This inhibition curtails cancer growth, leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Mitotax 100mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Mitotax 100mg Injection during pregnancy poses a confirmed risk to the fetus, contraindicating its routine use. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Mitotax 100mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Mitotax 100mg Injection can induce adverse reactions that might impair driving ability. While driving isn't prohibited between treatment cycles, consider that this medication includes alcohol, potentially making driving inadvisable.
KidneySAFE IF PRESCRIBED
Mitotax 100mg Injection can be used safely by individuals with kidney conditions; no dosage modification is typically necessary. Nevertheless, consultation with a physician is advised if you have pre-existing kidney disease.
LiverCAUTION
Patients with liver impairment should use Mitotax 100mg Injection cautiously, potentially requiring dose modification. Severe hepatic dysfunction contraindicates the use of Mitotax 100mg Injection; physician consultation is advised.
What if you forget to take Mitotax 100mg Injection :
NA
Facts to Know About Mitotax 100mg Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane-Based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Taxanes: Antimicrotubule Agents |
